Advanced Biomed to Buy Acellent Technologies for $1.08M

Advanced Biomed Inc., a Nevada company, entered a share purchase agreement to acquire Acellent Technologies (Hong Kong) Co. Limited. The seller will transfer 10,000 ordinary shares of the target, representing 100% of the equity interest.

The purchase price is $1,080,000, paid through 270,000 shares of Advanced Biomed common stock valued at $4.00 per share. The closing will occur on a mutually agreed date after due diligence is completed and required regulatory approvals are obtained.

Acellent Technologies (Hong Kong) is described as providing AI-powered financial verification and audit solutions.